II. Medizinische Klinik und Poliklinik im SKK

Universitätsklinikum S-H
II. Medizinische Klinik und Poliklinik
im Städtischen Krankenhaus Kiel
Chemnitzstraße 33
24116 Kiel


Klinik Direktion:
Prof. Dr. Dr. Michael Kneba

Frau Schäfer
Telefon: 0431 1697-1201
Fax: -1202
E-Mail: sekretariat@med2.uni-kiel.de

Klinik für Innere Medizin II

Universitätsklinikum S-H
Klinik für Innere Medizin II
im Karl-Lennert-Krebszentrum Nord
Hämatologie und Onkologie
Arnold-Heller Straße 3, Haus 50
24105 Kiel


Prof. Dr. Dr. Michael Kneba

Frau Barg
Tel.: 0431 597-3493
Fax: -4739
E-Mail: Sekretariat Innere Med II

Sektion für Stammzell- und Immuntherapie

Universitätsklinikum S-H
Sektion für Stammzell- und Immuntherapie
Dr. Mildred-Scheel-Haus
Arnold-Heller Straße 3, Haus 43
24105 Kiel


Prof. Dr. M. Gramatzki

Frau Oatley
Telefon: 0431 597-5802
Fax: -5803

E-Mail: Sekretariat MSH



 Publikationen 2003

  • Arends J, Zürcher G, Fietkau R, Aulbert E, Frick B, Holm M, Kneba M, Mestrom HJ, Zander A
    DGEM-Leitlinie Enterale Ernährung
    Onkologe. Aktuel Ernaehr Med. 2003 28: 61-68
  • Beck C, Bock N, Proksch E, Kneba M, Schröder O.
    Aphonia as a rare prodomal symptom in a case of Churg-Strauss-Syndrome with coincident coeliac disease. A Case Report.
    Rheumatology . 2003; 42:1565-1566
  • Beck C, Schreiber K, Schreiber H, Rowley DA.
    c-kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serum.
    Eur J Immunol . 2003; 33:19-28
  • Claviez A, Horst H.-A., Santer R, Suttorp M.
    Neutrophil aggregates in a 13-year-old girl: a rare hematological phenomenon.
    Ann Hematol. 2003; 82:251-253
  • Dugas M, Messerer D, Hasford J, Haferlach T, Heinze B, Ludwig W, Rieder H, Schoch R, Schwartz S, Thiel E.
    German Multicenter Study Group for Adult ALL (GMALL): recruitment in comparison to ALL incidence and ist impact on study results.
    Ann Hematol. 2003; 82:83-87
  • Gökbuget N, Kneba M, Brüggemann M, Scheuring U, Reutzel R, Hoelzer D.
    Risk-adapted treatment according to minimal residual disease in adult ALL.
    Best Pract Res Clin Haematol. 2003; 15:639-652
  • Hoffmann C, Horst HA, Albrecht H, Schlote W.
    Progressive multifocal leukoencephalopathy with unusual inflammatory response during antiretroviral therapy.
    J Neurol Neurosurg Psychiatry. 2003; 74:1142-1144
  • Hoffmann C, Wolf E, Fätkenheuer G, Buhk T, Lorenzen T, Stoehr A, Plettenberg A, Stellbrink HJ, Jaeger H, Siebert U, Horst HA.
    Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.
    AIDS. 2003; 17:1521-1529
  • Klinman DM, Zeuner R, Yamada H, Gursel M, Currie D, Gursel I.
    Regulation of CpG-induced immune activation by suppressive oligodeoxynucleotides.
    Ann N Y Acad Sci. 2003; 1002:112-123
  • Krüger S, Schroers R, Rooney CM, Gahn B, Chen S-Y.
    Identifikation of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1.
    J Immunother 2003; 26:212-221
  • Mohr A, Heiss C, Bergmann I, Schrader C, Roemer FW, Lynch JA, Muhle C, Genant HK, Heller M.
    Value of micro-CT as an investigative tool for osteochondritis dissecans.
    Acta Radiol. 2003; 44:532-537
  • Moosig F, Graf D, Knorr-Spahr A, Zeuner RA, Böttcher S, Schröder JO.
    Monocyte and granulocyte phagocytosis of Escherichia coli particles in systemic lupus erythematosus is not reduced when compared to healthy controls.
    Lupus 2003; 12:490-492
  • Ritgen M, Lange A, Stilgenbauer St, Döhner H, Bretscher Ch, Bosse H, Stuhr A, Kneba M, Dreger P.
    Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia.
    Blood 2003; 101:2049-2053
  • Schmook T, Stockfleth E, Lischner S, Gahn B, Christophers E, Hauschild A.
    Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP).
    Clin Exp Dermatol. 2003; 28:31-33
  • Szczepanski T, van der Velden VHJ, Raff T, Jacobs DCH, van Wering ER, Brüggemann M, Kneba M, van Dongen JJM.
    Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of secondary T-ALL.
    Leukemia 2003 17:2149-2156
  • Teymoortash A, Tiemann M, Schrader C, Hartmann O, Werner JA.
    Transforming growth factor beta in chronic obstructive sialadenitis of human submandibular gland.
    Arch Oral Biol. 2003; 48:111-116.
  • van Dongen JJM, Langerak AW, Brüggemann M, Evans PAS, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JHJM, Droese J, Gonzales D, Bastard C, White HE, Spaargaren M, Gonzales M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA.
    Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
    Leukemia 2003;17:2257-2317
  • van Krieken JH, Langerak AW, San Miguel JF, Parreira A, Smith JL, Morgan GM, Kneba M, Macintyre EA, van Dongen JJ.
    Clonality analysis for antigen receptor genes: preliminary results from the Biomed-2 concerted action PL 96-3936.
    Hum Pathol. 2003; 34:359-61
  • Verthelyi D, Zeuner RA.
    Differential signaling by CpG DNA in DCs and B cells: not just TLR9.
    Trends in Immunology 2003; 24:519-522
  • Wagner HJ, Sili U, Gahn B, Vigouroux S, Huls MH, Xie W, Vignali D, Brenner MK, Heslop HE, Rooney CM.
    Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15.
    Cytotherapy 2003; 5:231-240
  • Zeuner RA, Klinman DM, Illei G, Yarboro C, Ishii KJ, Gursel M, Verthelyi D
    Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides.
    Rheumatology 2003; 42:563-569
  • Zeuner RA, Verthelyi D, Gursel M, Ishii KJ, Klinman DM.
    Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis.
    Arthritis Rheum 2003; 48:1701-1707